|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferrari P, Jenab M, Norat T, Moskal A,
Slimani N, Olsen A, Tjønneland A, Overvad K, Jensen MK,
Boutron-Ruault MC, et al: Lifetime and baseline alcohol intake and
risk of colon and rectal cancers in the European prospective
investigation into cancer and nutrition (EPIC). Int J Cancer.
121:2065–2072. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Corté H, Manceau G, Blons H and
Laurent-Puig P: MicroRNA and colorectal cancer. Dig Liver Dis.
44:195–200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peters U, Jiao S, Schumacher FR, Hutter
CM, Aragaki AK, Baron JA, Berndt SI, Bézieau S, Brenner H,
Butterbach K, et al: Colon Cancer Family Registry and the Genetics
and Epidemiology of Colorectal Cancer Consortium: Identification of
genetic susceptibility loci for colorectal tumors in a genome-wide
meta-analysis. Gastroenterology. 144:799–807.e724. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Greenman C, Stephens P, Smith R, Dalgliesh
GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C,
et al: Patterns of somatic mutation in human cancer genomes.
Nature. 446:153–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kusenda B, Mraz M, Mayer J and Pospisilova
S: MicroRNA biogenesis, functionality and cancer relevance. Biomed
Pap Med Fac Univ Palacky Olomouc Czech Repub. 150:205–215. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Place RF, Li LC, Pookot D, Noonan EJ and
Dahiya R: MicroRNA-373 induces expression of genes with
complementary promoter sequences. Proc Natl Acad Sci USA.
105:1608–1613. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vasudevan S, Tong Y and Steitz JA:
Switching from repression to activation: microRNAs can up-regulate
translation. Science. 318:1931–1934. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Santarpia L, Nicoloso M and Calin GA:
MicroRNAs: a complex regulatory network drives the acquisition of
malignant cell phenotype. Endocr Relat Cancer. 17:F51–F75. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mattie MD, Benz CC, Bowers J, Sensinger K,
Wong L, Scott GK, Fedele V, Ginzinger D, Getts R and Haqq C:
Optimized high-throughput microRNA expression profiling provides
novel biomarker assessment of clinical prostate and breast cancer
biopsies. Mol Cancer. 5:242006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Grady WM, Parkin RK, Mitchell PS, Lee JH,
Kim YH, Tsuchiya KD, Washington MK, Paraskeva C, Willson JK, Kaz
AM, et al: Epigenetic silencing of the intronic microRNA
hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene.
27:3880–3888. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lanza G, Ferracin M, Gafà R, Veronese A,
Spizzo R, Pichiorri F, Liu CG, Calin GA, Croce CM and Negrini M:
mRNA/microRNA gene expression profile in microsatellite unstable
colorectal cancer. Mol Cancer. 6:542007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gaur A, Jewell DA, Liang Y, Ridzon D,
Moore JH, Chen C, Ambros VR and Israel MA: Characterization of
microRNA expression levels and their biological correlates in human
cancer cell lines. Cancer Res. 67:2456–2468. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saito Y, Suzuki H and Hibi T: The role of
microRNAs in gastrointestinal cancers. J Gastroenterol. 44:(Suppl
19). 18–22. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin
and cancer metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
18
|
Noonan EJ, Place RF, Basak S, Pookot D and
Li LC: miR-449a causes Rb-dependent cell cycle arrest and
senescence in prostate cancer cells. Oncotarget. 1:349–358.
2010.PubMed/NCBI
|
|
19
|
Panarelli NC and Yantiss RK: Microrna
expression in selected carcinomas of the gastrointestinal tract.
Pathol Res Int. 2011:1246082011. View Article : Google Scholar
|
|
20
|
Wu D, Yang G, Zhang L, Xue J, Wen Z and Li
M: Genome-wide association study combined with biological context
can reveal more disease-related SNPs altering microRNA target seed
sites. BMC Genomics. 15:6692014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jadad AR, Moore RA, Carroll D, Jenkinson
C, Reynolds DJ, Gavaghan DJ and McQuay HJ: Assessing the quality of
reports of randomized clinical trials: is blinding necessary?
Control Clin Trials. 17:1–12. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Bi J, Liu X, Li K, Di J and Wang
B: Has-miR-146a polymorphism (rs2910164) and cancer risk: a
meta-analysis of 19 case-control studies. Mol Biol Rep.
39:4571–4579. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu X, Yang X, Ru G, Wu Y, Zhang S, Xing C,
Wu Y and Cao J: miR-146a gene polymorphism rs2910164 and the risk
of digestive tumors: a meta-analysis of 21 case-control studies.
Oncol Rep. 31:472–479. 2014.PubMed/NCBI
|
|
24
|
Min KT, Kim JW, Jeon YJ, Jang MJ, Chong
SY, Oh D and Kim NK: Association of the miR-146aC>G, 149C>T,
196a2C>T, and 499A>G polymorphisms with colorectal cancer in
the Korean population. Mol Carcinog. 51:(Suppl 1). E65–E73. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hezova R, Kovarikova A, Bienertova-Vasku
J, Sachlova M, Redova M, Vasku A, Svoboda M, Radova L, Kiss I,
Vyzula R, et al: Evaluation of SNPs in miR-196-a2, miR-27a and
miR-146a as risk factors of colorectal cancer. World J
Gastroenterol. 18:2827–2831. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma L, Zhu L, Gu D, Chu H, Tong N, Chen J,
Zhang Z and Wang M: A genetic variant in miR-146a modifies
colorectal cancer susceptibility in a Chinese population. Arch
Toxicol. 87:825–833. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lv M, Dong W, Li L and Zhang L, Su X, Wang
L, Gao L and Zhang L: Association between genetic variants in
pre-miRNA and colorectal cancer risk in a Chinese population. J
Cancer Res Clin Oncol. 139:1405–1410. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vinci S, Gelmini S, Mancini I, Malentacchi
F, Pazzagli M, Beltrami C, Pinzani P and Orlando C: Genetic and
epigenetic factors in regulation of microRNA in colorectal cancers.
Methods. 59:138–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu X, Li L, Shang M, Zhou J, Song X, Lu X,
Wang J, Ying B and Wang L: Association between microRNA genetic
variants and susceptibility to colorectal cancer in Chinese
population. Tumour Biol. 35:2151–2156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Parlayan C, Ikeda S, Sato N, Sawabe M,
Muramatsu M and Arai T: Association analysis of single nucleotide
polymorphisms in miR-146a and miR-196a2 on the prevalence of cancer
in elderly Japanese: a case-control study. Asian Pac J Cancer Prev.
15:2101–2107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu L, Chu H, Gu D, Ma L, Shi D, Zhong D,
Tong N, Zhang Z and Wang M: A functional polymorphism in
miRNA-196a2 is associated with colorectal cancer risk in a Chinese
population. DNA Cell Biol. 31:350–354. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhan JF, Chen LH, Chen ZX, Yuan YW, Xie
GZ, Sun AM and Liu Y: A functional variant in microRNA-196a2 is
associated with susceptibility of colorectal cancer in a Chinese
population. Arch Med Res. 42:144–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen H, Sun LY, Chen LL, Zheng HQ and
Zhang QF: A variant in microRNA-196a2 is not associated with
susceptibility to and progression of colorectal cancer in Chinese.
Intern Med J. 42:e115–e119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Z, Sun X, Wang Y, Liu X, Xuan Y and
Hu S: Association between miR-27a genetic variants and
susceptibility to colorectal cancer. Diagn Pathol. 9:1462014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao LB, Li LJ, Pan XM, Li ZH, Liang WB,
Bai P, Zhu YH and Zhang L: A genetic variant in the promoter region
of miR-34b/c is associated with a reduced risk of colorectal
cancer. Biol Chem. 394:415–420. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Oh J, Kim JW, Lee BE, Jang MJ, Chong SY,
Park PW, Hwang SG, Oh D and Kim NK: Polymorphisms of the
pri-miR-34b/c promoter and TP53 codon 72 are associated with risk
of colorectal cancer. Oncol Rep. 31:995–1002. 2014.PubMed/NCBI
|
|
37
|
Pan XM, Sun RF, Li ZH, Guo XM, Zhang Z,
Qin HJ, Xu GH and Gao LB: A let-7 KRAS rs712 polymorphism increases
colorectal cancer risk. Tumour Biol. 35:831–835. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang FJ, Ding Y, Mao YY, Jing FY, Zhang
ZY, Jiang LF, Guo JF, Sun XJ, Jin MJ and Chen K: Associations
between hsa-miR-603 polymorphism, lifestyle-related factors and
colorectal cancer risk. Cancer Biomark. 14:225–231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ryan BM, McClary AC, Valeri N, Robinson D,
Paone A, Bowman ED, Robles AI, Croce C and Harris CC: rs4919510 in
hsa-mir-608 is associated with outcome but not risk of colorectal
cancer. PLoS One. 7:e363062012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
De Ruyck K, Duprez F, Ferdinande L, Mbah
C, Rios-Velazquez E, Hoebers F, Praet M, Deron P, Bonte K, Speel
EJ, et al: A let-7 microRNA polymorphism in the KRAS 3′-UTR is
prognostic in oropharyngeal cancer. Cancer Epidemiol. 38:591–598.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhou B, Dong LP, Jing XY, Li JS, Yang SJ,
Wang JP and Zhao LF: Association between miR-146aG>C and
miR-196a2C>T polymorphisms and the risk of hepatocellular
carcinoma in a Chinese population. Tumour Biol. 35:7775–7780. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Palmieri A, Carinci F, Martinelli M,
Pezzetti F, Girardi A, Cura F, Rubini C and Scapoli L: Role of the
MIR146A polymorphism in the origin and progression of oral squamous
cell carcinoma. Eur J Oral Sci. 122:198–201. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang N, Li Y, Zhu LJ, Zhou RM, Jin W, Guo
XQ, Wang CM, Chen ZF and Liu W: A functional polymorphism
rs11614913 in microRNA-196a2 is associated with an increased risk
of colorectal cancer although not with tumor stage and grade.
Biomed Rep. 1:737–742. 2013.PubMed/NCBI
|
|
44
|
Tao T, Chen S, Xu B, Liu C, Wang Y, Huang
Y and Chen M: Association between hsa-miR-34b/c rs4938723 T > C
promoter polymorphism and cancer risk: a meta-analysis based on
6,036 cases and 6,204 controls. Chin J Cancer Res. 26:315–322.
2014.PubMed/NCBI
|
|
45
|
Li YJ, Zhang ZY, Mao YY, Jin MJ, Jing FY,
Ye ZH and Chen K: A genetic variant in MiR-146a modifies digestive
system cancer risk: a meta-analysis. Asian Pac J Cancer Prev.
15:145–150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang J, Wang Q, Liu H, Shao N, Tan B,
Zhang G, Wang K, Jia Y, Ma W, Wang N, et al: The association of
miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with
cancer risk: a meta-analysis of 32 studies. Mutagenesis.
27:779–788. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dikeakos P, Theodoropoulos G, Rizos S,
Tzanakis N, Zografos G and Gazouli M: Association of the
miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms
with gastric cancer risk and survival in the Greek population. Mol
Biol Rep. 41:1075–1080. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Song MY, Su HJ, Zhang L, Ma JL, Li JY, Pan
KF and You WC: Genetic polymorphisms of miR-146a and miR-27a, H.
pylori infection, and risk of gastric lesions in a Chinese
population. PLoS One. 8:e612502013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zeng Y, Sun QM, Liu NN, Dong GH, Chen J,
Yang L and Wang B: Correlation between pre-miR-146a C/G
polymorphism and gastric cancer risk in Chinese population. World J
Gastroenterol. 16:3578–3583. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhou F, Zhu H, Luo D, Wang M, Dong X, Hong
Y, Lu B, Zhou Y, Zhou J, Zhang Z, et al: A functional polymorphism
in Pre-miR-146a is associated with susceptibility to gastric cancer
in a Chinese population. DNA Cell Biol. 31:1290–1295. 2012.
View Article : Google Scholar : PubMed/NCBI
|
